Kishimoto S et al. |
2-arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism. |
2003 |
J. Biol. Chem. |
pmid:12711605
|
Maccarrone M et al. |
Activation of human platelets by 2-arachidonoylglycerol is enhanced by serotonin. |
2003 |
Thromb. Haemost. |
pmid:12574815
|
Walter L et al. |
Nonpsychotropic cannabinoid receptors regulate microglial cell migration. |
2003 |
J. Neurosci. |
pmid:12598628
|
Fride E et al. |
Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor. |
2003 |
Eur. J. Pharmacol. |
pmid:12568912
|
Patel S et al. |
Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity. |
2003 |
J. Pharmacol. Exp. Ther. |
pmid:12808005
|
Franklin A et al. |
Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. |
2003 |
J. Neurosci. |
pmid:12944505
|
Liu J et al. |
Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor. |
2003 |
J. Biol. Chem. |
pmid:12949078
|
Gaetani S et al. |
Anandamide hydrolysis: a new target for anti-anxiety drugs? |
2003 |
Trends Mol Med |
pmid:14604824
|
Lépicier P et al. |
Endocannabinoids protect the rat isolated heart against ischaemia. |
2003 |
Br. J. Pharmacol. |
pmid:12813004
|
Marsicano G et al. |
CB1 cannabinoid receptors and on-demand defense against excitotoxicity. |
2003 |
Science |
pmid:14526074
|
van der Stelt M et al. |
Acute neuronal injury, excitotoxicity, and the endocannabinoid system. |
2002 Oct-Dec |
Mol. Neurobiol. |
pmid:12428763
|
Sugiura T et al. |
Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052034
|
Fowler CJ and Jacobsson SO |
Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development? |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052035
|
Högestätt ED and Zygmunt PM |
Cardiovascular pharmacology of anandamide. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052048
|
Sugiura T and Waku K |
Cannabinoid receptors and their endogenous ligands. |
2002 |
J. Biochem. |
pmid:12097154
|
Maccarrone M et al. |
Endocannabinoid degradation, endotoxic shock and inflammation. |
2002 |
Curr Drug Targets Inflamm Allergy |
pmid:14561206
|
Kozak KR et al. |
Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. |
2002 |
J. Biol. Chem. |
pmid:12244105
|
Dinh TP et al. |
Brain monoglyceride lipase participating in endocannabinoid inactivation. |
2002 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:12136125
|
Matias I et al. |
Presence and regulation of the endocannabinoid system in human dendritic cells. |
2002 |
Eur. J. Biochem. |
pmid:12153574
|
Gubellini P et al. |
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. |
2002 |
J. Neurosci. |
pmid:12177188
|